VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
-4.07%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
–
Cap. Flow
+$120M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
79.86%
Holding
27
New
25
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Jasper Therapeutics
JSPR
|
$22.9M |
| 2 |
Lantheus
LNTH
|
$18M |
| 3 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$15M |
| 4 |
Immunocore
IMCR
|
$10M |
| 5 |
ADMA Biologics
ADMA
|
$7.61M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 95.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xeris Biopharma Holdings
XERS
$1.26B
| – | – |
0
| – | – |
|
|
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
0
| – | – |
|